End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.47 CNY | +0.81% | +0.27% | -22.83% |
Apr. 26 | Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19 | MT |
Apr. 01 | Daan Gene Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
Sales 2022 | 12.05B 1.66B | Sales 2023 | 1.18B 163M | Capitalization | 13.59B 1.87B |
---|---|---|---|---|---|
Net income 2022 | 5.41B 747M | Net income 2023 | 105M 14.49M | EV / Sales 2022 | 1.54 x |
Net cash position 2022 | 3.33B 460M | Net cash position 2023 | 2.03B 281M | EV / Sales 2023 | 9.78 x |
P/E ratio 2022 |
4.03
x | P/E ratio 2023 |
130
x | Employees | 1,968 |
Yield 2022 |
11.2% | Yield 2023 |
0.15% | Free-Float | 65.64% |
1 day | +0.81% | ||
1 week | +0.27% | ||
Current month | -10.32% | ||
1 month | -8.79% | ||
3 months | -13.24% | ||
6 months | -23.07% | ||
Current year | -22.83% |
Managers | Title | Age | Since |
---|---|---|---|
Luo Huang
CEO | Chief Executive Officer | 44 | 21-05-31 |
Wei Jie Zhang
DFI | Director of Finance/CFO | 53 | 15-03-25 |
Xi Wen Jiang
BRD | Director/Board Member | 42 | 21-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zheng Fu Zhu
BRD | Director/Board Member | 60 | 22-05-26 |
Zhe Qiang Xue
CHM | Chairman | 36 | 22-07-03 |
Li Qiang Huang
BRD | Director/Board Member | 57 | 03-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 2 M€ | -16.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 7.47 | +0.81% | 11,464,860 |
24-04-25 | 7.41 | +0.27% | 8,135,412 |
24-04-24 | 7.39 | -1.99% | 12,964,490 |
24-04-23 | 7.54 | +0.27% | 10,539,060 |
24-04-22 | 7.52 | +0.94% | 11,779,980 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-22.83% | 1.45B | |
-19.01% | 56.28M |
- Stock Market
- Equities
- 002030 Stock